ATE342354T1 - Serinprotease-spzifischer moniklonaler antikörper und seine verwendung - Google Patents
Serinprotease-spzifischer moniklonaler antikörper und seine verwendungInfo
- Publication number
- ATE342354T1 ATE342354T1 AT99926899T AT99926899T ATE342354T1 AT E342354 T1 ATE342354 T1 AT E342354T1 AT 99926899 T AT99926899 T AT 99926899T AT 99926899 T AT99926899 T AT 99926899T AT E342354 T1 ATE342354 T1 AT E342354T1
- Authority
- AT
- Austria
- Prior art keywords
- neurosin
- antibody
- moniclonal
- serine protease
- strain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18750698 | 1998-07-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE342354T1 true ATE342354T1 (de) | 2006-11-15 |
Family
ID=16207265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99926899T ATE342354T1 (de) | 1998-07-02 | 1999-07-02 | Serinprotease-spzifischer moniklonaler antikörper und seine verwendung |
Country Status (11)
Country | Link |
---|---|
US (1) | US6645734B2 (de) |
EP (1) | EP1092767B1 (de) |
JP (1) | JP4369055B2 (de) |
AT (1) | ATE342354T1 (de) |
AU (1) | AU755340B2 (de) |
CA (1) | CA2332131C (de) |
DE (1) | DE69933565T2 (de) |
DK (1) | DK1092767T3 (de) |
ES (1) | ES2273496T3 (de) |
PT (1) | PT1092767E (de) |
WO (1) | WO2000001807A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569684B2 (en) | 2000-01-06 | 2003-05-27 | University Of Central Florida | Method of identifying and treating invasive carcinomas |
US20040096915A1 (en) * | 2000-10-27 | 2004-05-20 | Diamandis Eleftherios P. | Methods for detecting ovarian cancer |
US6962793B2 (en) | 2000-10-27 | 2005-11-08 | Mount Sinai Hospital | Methods for detecting Alzheimers disease |
US7666981B1 (en) | 2002-05-10 | 2010-02-23 | University Of Central Florida Research Foundation, Inc. | Inhibitors of prostasin |
DE60324796D1 (de) * | 2002-05-21 | 2009-01-02 | Mayo Foundation | Verfahren und materialien zur behandlung und diagnose von mit kallikrein-6 zusammenhängenden entzündlichen zuständen |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
US8497072B2 (en) | 2005-11-30 | 2013-07-30 | Abbott Laboratories | Amyloid-beta globulomer antibodies |
PL1954718T3 (pl) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Przeciwciała skierowane przeciwko A globulomerowi, ich reszty wiążące antygeny, odpowiednie hybrydomy, kwasy nukleinowe, wektory, komórki gospodarze, sposoby wytwarzania tych przeciwciał, kompozycje zawierające te przeciwciała, zastosowania tych przeciwciał i sposoby stosowania tych przeciwciał |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
EP2486928A1 (de) | 2007-02-27 | 2012-08-15 | Abbott GmbH & Co. KG | Verfahren zur Behandlung von Amyloidosen |
US20100233162A1 (en) * | 2007-08-30 | 2010-09-16 | Bengt Agerup | LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS |
EP2445925A1 (de) * | 2009-06-25 | 2012-05-02 | Bristol-Myers Squibb Company | Proteinaufreinigung mittels präzipitation von caprylsäure (octansäure) |
US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
WO2012024187A1 (en) | 2010-08-14 | 2012-02-23 | Abbott Laboratories | Amyloid-beta binding proteins |
WO2016073401A1 (en) | 2014-11-03 | 2016-05-12 | Bristol-Myers Squibb Company | Use of caprylic acid precipitation for protein purification |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL105793A0 (en) * | 1992-05-28 | 1993-09-22 | Lilly Co Eli | Protease and related dna compounds |
JPH09149790A (ja) * | 1995-09-29 | 1997-06-10 | Suntory Ltd | 新規セリンプロテアーゼ |
AU4480797A (en) * | 1996-09-13 | 1998-04-02 | Dana-Farber Cancer Institute | Protease m, a novel serine protease |
-
1999
- 1999-07-02 ES ES99926899T patent/ES2273496T3/es not_active Expired - Lifetime
- 1999-07-02 AU AU43966/99A patent/AU755340B2/en not_active Ceased
- 1999-07-02 WO PCT/JP1999/003578 patent/WO2000001807A1/ja active IP Right Grant
- 1999-07-02 AT AT99926899T patent/ATE342354T1/de active
- 1999-07-02 DK DK99926899T patent/DK1092767T3/da active
- 1999-07-02 EP EP99926899A patent/EP1092767B1/de not_active Expired - Lifetime
- 1999-07-02 CA CA002332131A patent/CA2332131C/en not_active Expired - Fee Related
- 1999-07-02 PT PT99926899T patent/PT1092767E/pt unknown
- 1999-07-02 DE DE69933565T patent/DE69933565T2/de not_active Expired - Lifetime
- 1999-07-02 JP JP2000558197A patent/JP4369055B2/ja not_active Expired - Fee Related
-
2000
- 2000-12-21 US US09/741,171 patent/US6645734B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1092767A4 (de) | 2001-10-24 |
DK1092767T3 (da) | 2006-11-27 |
CA2332131C (en) | 2007-05-15 |
WO2000001807A1 (fr) | 2000-01-13 |
EP1092767A1 (de) | 2001-04-18 |
US6645734B2 (en) | 2003-11-11 |
DE69933565T2 (de) | 2007-07-05 |
CA2332131A1 (en) | 2000-01-13 |
JP4369055B2 (ja) | 2009-11-18 |
DE69933565D1 (de) | 2006-11-23 |
AU4396699A (en) | 2000-01-24 |
PT1092767E (pt) | 2007-01-31 |
AU755340B2 (en) | 2002-12-12 |
ES2273496T3 (es) | 2007-05-01 |
EP1092767B1 (de) | 2006-10-11 |
US20010016331A1 (en) | 2001-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE342354T1 (de) | Serinprotease-spzifischer moniklonaler antikörper und seine verwendung | |
ATE488576T1 (de) | Schnellproduktion monoklonaler antikörper | |
ATE295376T1 (de) | Monoklonaler antikörper als hemmstoff für gm-csf, il-3, il-5 und andere zytokine und deren verwendung | |
EP0176355A3 (de) | Immunologisches Verfahren unabhängig von Antigenen | |
AU577745B2 (en) | Somatic human hybridoma fusion partner for the production of human monoclonal antibodies | |
DK1654286T3 (da) | Humaniseret anti-CD4-antistof med immunsuppressive egenskaber | |
DK1414858T3 (da) | Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf | |
ATE440868T1 (de) | Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen | |
DK1562972T3 (da) | Modifikation af FcRn-bindingsaffiniteter eller serumhalveringstider for antistoffer ved mutagenese | |
ATE382683T1 (de) | Monoklonales antikörper gegen das hcv kernantigen | |
DE59813519D1 (de) | Mutiertes ScFv-Fragment des OKT-3 Antikörpers | |
EP1167537A4 (de) | Verfahren zur Herstellung von monoklonalen Antikörpern | |
DE69808609T2 (de) | Antagonistische anti-avb3 integrin antikörper | |
NZ591541A (en) | Pcsk9 antagonists | |
ATE81867T1 (de) | Monoklonaler antikoerper mit hoher affinitaet zum digoxin. | |
ATE277083T1 (de) | Antikörper, die spezifisch für fullerene sind | |
DK1144006T3 (da) | Synergistisk inhibering af HIV-1-fusion og -binding, præparater og antistoffer dertil | |
WO2004106385A3 (en) | Monoclonal antibodies specific for buprenorphine and metabolites thereof | |
SI1396501T1 (sl) | Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr | |
DE69224134T2 (de) | Monoklonale Antikörper gegen Hepatitis-C-Virus | |
EP1879029A4 (de) | Immunnachweiskit in verbindung mit neuroglobin-enzym sowie verwendung davon | |
JP2002085058A5 (de) | ||
DE3686277D1 (de) | Verfahren zur auslese von hybridomen, die spezifische antikoerper gegen unzugaengliche zelloberflaecheantigene erzeugen. | |
WO2005003379A3 (fr) | Procede automatise de criblage a grande echelle de cellules secretant des anticorps monoclonaux | |
WO2005021711A3 (en) | Approach for obtaining monoclonal antibodies to cell surface proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1092767 Country of ref document: EP |